Risk Factors for Thrombocytopenia in Adult Chinese Patients Receiving Linezolid Therapy
Authors:
- 1 December 2012
- journal article
- Published by Elsevier in Current Therapeutic Research
- Vol. 73 (6) , 195-206
Abstract
No abstract availableKeywords
Funding Information
- Innovation Fund (10KMM41)
This publication has 23 references indexed in Scilit:
- Linezolid in the treatment of MDR-TB: a retrospective clinical studyThe International Journal of Tuberculosis and Lung Disease, 2012
- Population Pharmacokinetic and Pharmacodynamic Analysis of Linezolid and a Hematologic Side Effect, Thrombocytopenia, in Japanese PatientsAntimicrobial Agents and Chemotherapy, 2011
- Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunctionInternational Journal of Antimicrobial Agents, 2010
- Population Pharmacokinetic Analysis of Linezolid in Patients With Infectious Disease: Application to Lower Body Weight and Elderly PatientsThe Journal of Clinical Pharmacology, 2009
- Renal function as a predictor of linezolid-induced thrombocytopeniaInternational Journal of Antimicrobial Agents, 2009
- In Vitro Activities of Linezolid and Tigecycline Against Methicillin-Resistant Staphylococcus aureus StrainsMicrobial Drug Resistance, 2008
- Pharmacokinetics of Linezolid in Subjects with Renal DysfunctionAntimicrobial Agents and Chemotherapy, 2003
- Worldwide Assessment of Linezolid's Clinical Safety and Tolerability: Comparator-Controlled Phase III StudiesAntimicrobial Agents and Chemotherapy, 2003
- Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use ProgramClinical Infectious Diseases, 2003
- Hematologic Effects of Linezolid: Summary of Clinical ExperienceAntimicrobial Agents and Chemotherapy, 2002